After the opening bell the Dow Jones industrial average was down 0.5%. The Standard & Poor's 500 stock index was off 0.5%, and the Nasdaq composite was down 0.6%.
Investors entered the day on a cautious note after retail sales in January dropped 0.4%, which was below estimates of a fall of 0.1%.
First-time jobless claims for last week also came in weaker-than-expected, rising 8,000 to 339,000. Despite the slight rise in the number of Americans filing for first-time unemployment benefits, the job market remains "fairly stable" and there has been "no major shift in labor market conditions," Michael Gapen, an economist at Barclays, said in a research report.
Top Gold Companies To Own In Right Now: Allison Transmission Holdings Inc (ALSN)
Allison Transmission Holdings, Inc. (Allison), incorporated on June 22, 2007, designs and manufactures commercial and military fully-automatic transmissions. The Company is a manufacturer of fully-automatic transmissions for medium- and heavy-duty commercial vehicles, medium- and heavy-tactical the United States military vehicles and hybrid-propulsion systems for transit buses. Allison transmissions are used in a range of applications, including on-highway trucks (distribution, refuse, construction, fire and emergency), buses (primarily school and transit), motorhomes, off-highway vehicles and equipment (energy and mining) and military vehicles (wheeled and tracked). In January 2014, the Company opened a facility in the Netherlands to serve customers across Europe, the Middle East and Africa.
Allison transmissions are sold under the Allison Transmission brand name and remanufactured transmissions are sold under the ReTran brand name. The Company has 12 transmission product lines with over 100 different product models. Allison transmissions are included in more than 2,500 vehicle configurations, which are compatible with more than 500 combinations of engine brands, models and ratings globally. In addition to the Company's product offerings, the Company has products under development, including the TC10, a Class 8 metro truck fully-automatic transmission, and the H 3000 and the H 4000 hybrid-propulsion systems designed for use in medium- and heavy-duty commercial trucks and buses.
North America
The Company is a manufacturer of fully-automatic transmissions for the on-highway medium- and heavy-duty commercial vehicle markets in North America. The Company's core North American on-highway market includes Class 4-5, Class 6-7 and Class 8 straight trucks, conventional transit, shuttle and coach buses, school buses and motorhomes. Class 8 trucks are subdivided into two markets: straight and tractor. The Company sells its transmissions in the North American on-highway mar! ket to original equipment manufacturers (OEMs), including Blue Bird, Daimler, Hino, Navistar, PACCAR, Spartan Motors and Volvo. These OEMs, in turn, install the Company's transmissions in vehicles in which its transmission is either the exclusive transmission available or is specifically requested by end users who are choosing between a manual transmission, an AMT or a fully-automatic transmission. The Company's vehicle class in North America include Class 4-5 Trucks, Class 6-7 Trucks, Class 8 Straight Trucks, Buses and
Motorhomes
Class 4-5 trucks are used in urban applications, including distribution, commercial lease and rental, as well as ambulance. The Company is the transmission supplier to the Navistar Class 4-5 TerraStar truck. Class 6-7 trucks are used in urban applications, including larger distribution, commercial lease and rental, ambulance, rescue and fire trucks. The Company's transmissions are used in Class 6-7 buses. The Company supplies its transmissions for all of the school buses produced in North America. The bus market also encompasses non-hybrid transit and conventional coach and shuttle buses. The Company sells its transmissions for use in larger motorhomes ( types A). The Company typically sells to the chassis manufacturers, such as Navistar and Daimler, that supply body manufacturers, such as Thor Industries, Winnebago Industries and Fleetwood RV. As of December 31, 2012, the Company has delivered over 5,000 H 40/50 EP hybrid-propulsion transit bus systems globally to 246 cities in 14 countries. The Company's customers in this North American end market are typically city, state and federal governmental entities. The Company has provided products used in vehicles and equipment, which serve energy, mining and construction applications. Its customers include Halliburton Company, Baker Hughes, Weatherford International, National Oilwell Varco, and Key Energy Services. The Company also provides heavy-duty transmissions used in mining trucks, specialty and co! nstructio! n vehicles. Mining applications include trucks used to haul various commodities and other products, including rigid dump trucks, underground trucks and long-haul tractor trailer trucks with load capacities between 40 to 110 tons. Specialty vehicles using the Company's heavy-duty transmissions include airport rescue and firefighting vehicles and heavy-equipment transporters.
Outside North America
The Company is a manufacturer of fully-automatic transmissions for the commercial vehicle markets outside of North America. Within Europe, the Company serves Western European developed markets, as well as Russian and Eastern European emerging markets. The Company's on-highway customers in these markets are Daimler, Iveco, Scania, and Volvo. Fully-automatic transmission technology has approximately a 6% market share in European truck applications. The Company supplies transmissions to European OEMs. The Company is the exclusive transmission in refuse chassis with Daimler, Dennis Eagle and Renault SA. The Company also supply mining OEMs, such as Atlas Copco UK, Perlini Equipment, Sandvik AB and Terex. As of December 31, 2012, in China, the Company is the provider of fully-automatic commercial vehicle transmissions with a substantial installed base of over 45,000 Allison transmissions, including 30,000 units in transit buses, operated by 90 different bus fleets in 55 cities. The Company's off-highway transmissions are also used in China for energy, mining and construction, by OEM customers including 4th Petroleum and Yantai Jereh Oilfield Services Group Co. in energy applications and Qinhuangdao Tolian Speciality Transporter Co., Sany Group Co. and North Hauler in mining and construction applications. Australia and South Korea have OEMs with domestic production capabilities for which the Company is a supplier, including Iveco, Hyundai Motor Company and Daewoo International Corporation.
Military
The Company sells all of the transmissions for medium- and heavy-tac! tical whe! eled vehicle platforms, including the Family of Medium Tactical Vehicles, Armored Security Vehicles, Heavy Expanded Mobility Tactical Trucks, Heavy Equipment Transporters, Palletized Loading Systems, M915 Series Trucks, Medium Tactical Vehicle Replacements and the Logistic Vehicle System Replacement. In addition, the Company supplied transmissions for Mine-Resistant Ambush Protected (MRAP) Vehicles and the MRAP All Terrain Vehicle and for all three potential manufacturers of the Joint Light Tactical Vehicles. Transmissions for the Company's wheeled vehicle platforms are sold to OEMs, including BAE, Daimler, General Dynamics Land Systems, Oshkosh, Navistar and Textron Marine & Land Systems.
The Company is the supplier on two of the three key tracked vehicle platforms, the Abrams tank and the M113 family of vehicles, which are sold directly to the United States military. Additionally, the Company sells parts kits to licensees for the production of transmissions for tracked vehicles manufactured outside North America. The Company has been selected as the transmission supplier for the prime contractors bidding for the United States Army ground combat vehicle.
Service Parts, Support, Equipment and Other (Aftermarket)
Aftermarket provides the Company with a source of revenues as the installed base of vehicles and equipment utilizing the Company's transmissions. The Company has assembled a global network of approximately 1,400 distributor and dealer locations to sells, service and support its transmissions. As part of the Company's brand strategy, its independent distributors and dealers are required to sell genuine Allison-branded parts. The Company offers remanufactured transmissions under its ReTran brand. The Company also provides support equipment to its OEMs to assist in installing new Allison transmissions into vehicles.
The Company competes with Ford Motor Company, Eaton Corp., Voith GmbH, ZF Friedrichshafen AG, BAE, Caterpillar Inc., Twin Disc, Inco! rporated,! Komatsu, Ltd., Aisin Seiki Co., Ltd., JATCO Ltd, Mitsubishi Fuso Truck and Bus Corporation, Hino, Isuzu and Nissan Diesel, Danyang Winstar Auto Parts Co., Ltd., Tata, Ashok Leyland, JCBL Ltd., Asia Motor Works Limited, BEML, Renk AG and L-3 Communications Corporation.
Advisors' Opinion:- [By Ben Levisohn]
2Q14 Machinery results are likely to reflect what we view as a still mixed but improving macroeconomic environment that we think could support pockets of strength in Machinery end markets. In particular, we think both North American truck and North American energy markets continue to improve while global construction markets look supportive of continued solid/better-than-expected results (mostly from improved margin) in Caterpillar’s Construction segment. Solid truck, energy and construction markets seem supportive of earnings for Caterpillar as well as truck suppliers Cummins (CMI) and Allison Transmission Holdings (ALSN)…
- [By Rich Duprey]
Approving an increase in the quarterly cash dividend paid to shareholders, transmission manufacturer Allison Transmissions (NYSE: ALSN ) �announced today that its board of directors doubled the payout from�$0.06�per share to�$0.12�per share while also providing preliminary estimates for its first quarter, which ended March 31.
Top 5 Dow Dividend Stocks To Own Right Now: Griffin Land & Nurseries Inc.(GRIF)
Griffin Land & Nurseries, Inc., together with its subsidiaries, engages in real estate and landscape nursery businesses in the United States. The company?s real estate business consists of the ownership, construction, leasing, and management of commercial and industrial properties, as well as the development of residential subdivisions on real estate owned by it in Connecticut, Massachusetts, and Pennsylvania. Its landscape nursery business comprises the growing of containerized plants for sale principally to independent retail garden centers, rewholesalers, mass merchandisers, home centers, and landscape contractors. Griffin Land & Nurseries, Inc. was founded in 1970 and is based in New York City, New York.
Advisors' Opinion:- [By Dividends4Life]
Memberships and Peers: ADM is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: Bunge Limited (BG) with a 1.6% yield, Ingredion Incorporated (INGR) with a 2.4% yield and Griffin Land & Nurseries Inc. (GRIF) with a 0.7% yield.
Top 5 Dow Dividend Stocks To Own Right Now: ImmunoCellular Therapeutics Ltd (IMUC)
ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient�� own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies. The Company�� products include ICT-107, ICT-140, ICT-120, ICT-109 and DIAAD. ICT-107, the pipeline product, is a Phase II therapeutic dendritic cell (DC) vaccine for the treatment of glioblastoma multiforme (GBM), the common and lethal type of brain cancer. ICT-107 is designed to activate a patient�� immune system to target six different tumor-associated antigens. In February 2012, it acquired a world-wide license from the University of Pennsylvania and The John Hopkins University (JHU).
The Company in addition to ICT-107, is also developing other therapeutic DC vaccines: ICT-140 for ovarian cancer and ICT-121 for recurrent GBM. ICT-140 targets seven tumor-associated antigens expressed on ovarian cancer cells. ICT-107 is a DC vaccine that targets six different tumor-associated antigens that are found on patients��tumor cells; four of the six antigens are expressed on CSCs. The therapeutic vaccine is used subsequent to conventional therapy or concomitantly with chemotherapy in patients with newly diagnosed GBM. ICT-140 is a DC vaccine that targets seven different ovarian cancer antigens. ICT-121 is a DC vaccine that targets CD133 antigens; it has the potential to be a universal cancer vaccine because CD133 is widely expressed on CSCs from a majority of cancers. Data from this small study demonstrated that ICT-109 had a statistically ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets. The DIAAD (differential immunization for an! tigen and antibody discovery) platform it acquired from Molecular Discoveries utilizes immunological tolerization to accelerate the discovery of the molecular differences between diseased cells and their normal counterparts. The monoclonal antibodies produced by DIAAD provide the basis for the discovery and development of its potential diagnostic and therapeutic products.
The Company competes with Dendreon, Oncothyreon, Galena, Bavarian Nordic and Immunovaccine, Northwest Biotherapeutics, Prima Biomed, DCPrime, Roche/Genentech, Seattle Genetics, Bristol-Myers Squibb and Immunogen.
Advisors' Opinion:- [By Smith On Stocks]
Using my assumptions, the common of Agenus might be worth about $7.00 per share in early 2014 based on the royalties from the Glaxo vaccines and the net operating loss carry forward even if every other asset in the company were valued at zero. However, there may be substantial value in Agenus' internal vaccine programs in recurrent and newly diagnosed glioblastoma and the genital herpes vaccine. Based on a comparison to peer companies like Northwest Biotherapeutics (NWBO) and ImmunoCellular Therapeutics (IMUC), I believe that the internal programs at Agenus currently may be worth $150 million or $4.45 per share. Adding this to the value of the MAGE A-3 vaccine could produce a stock price of $11.00 in early 2014.
- [By Monica Gerson]
ImmunoCellular Therapeutics (NYSE: IMUC) dropped 11.05% to $1.3699. ImmunoCellular's trailing-twelve-month ROE is -59.80%.
Posted-In: market losersNews Movers & Shakers Intraday Update Markets
Top 5 Dow Dividend Stocks To Own Right Now: WisdomTree SmallCap Dividend Fund (DES)
WisdomTree SmallCap Dividend Fund (the Fund) seeks investment results that closely correspond to the price and yield performance of the WisdomTree SmallCap Dividend Index (the Index). The Index is a fundamentally weighted index measuring the performance of the small-capitalization segment of the United States dividend-paying market. The Index consists of the companies that compose the bottom 25% of the market capitalization of the WisdomTree Dividend Index after the 300 largest companies have been removed.
The Index is dividend weighted annually to reflect the proportionate share of the aggregate cash dividends each component company is projected to pay in the coming year, based on the most recently declared dividend per share. The Fund�� investment advisor is WisdomTree Asset Management, Inc., a wholly owned subsidiary of WisdomTree Investments, Inc.
Advisors' Opinion:- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some small dividend-paying stocks to your portfolio but don't have the time or expertise to hand-pick a few, the WisdomTree SmallCap Dividend ETF (NYSEMKT: DES ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The WisdomTree ETF's expense ratio -- its annual fee -- is a rather low 0.38%. It recently yielded more than 3%.
This ETF has performed well, beating the S&P 500 over the past three and five years. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver. - [By Philip Springer]
WisdomTree SmallCap Dividend ETF (DES) invests in dividend-paying small-cap companies that meet certain liquidity requirements. It then weights them by the dollar value of dividends they are expected to pay out over the next year.
No comments:
Post a Comment